These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35366773)

  • 1. Pharmacological Inhibition of Exosome Machinery: An Emerging Prospect in Cancer Therapeutics.
    Syeda S; Rawat K; Shrivastava A
    Curr Cancer Drug Targets; 2022; 22(7):560-576. PubMed ID: 35366773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes: Isolation, Analysis, and Applications in Cancer Detection and Therapy.
    Bu H; He D; He X; Wang K
    Chembiochem; 2019 Feb; 20(4):451-461. PubMed ID: 30371016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exo-MFA - A 13C metabolic flux analysis framework to dissect tumor microenvironment-secreted exosome contributions towards cancer cell metabolism.
    Achreja A; Zhao H; Yang L; Yun TH; Marini J; Nagrath D
    Metab Eng; 2017 Sep; 43(Pt B):156-172. PubMed ID: 28087332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer.
    Han QF; Li WJ; Hu KS; Gao J; Zhai WL; Yang JH; Zhang SJ
    Mol Cancer; 2022 Nov; 21(1):207. PubMed ID: 36320056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity.
    Ferguson SW; Nguyen J
    J Control Release; 2016 Apr; 228():179-190. PubMed ID: 26941033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cancer exosomes: Clinical implications, applications and challenges.
    Tang Z; Li D; Hou S; Zhu X
    Int J Cancer; 2020 Jun; 146(11):2946-2959. PubMed ID: 31671207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes in cancer development, metastasis, and immunity.
    Zhang L; Yu D
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):455-468. PubMed ID: 31047959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of exosomes for cancer research.
    Zhu L; Sun HT; Wang S; Huang SL; Zheng Y; Wang CQ; Hu BY; Qin W; Zou TT; Fu Y; Shen XT; Zhu WW; Geng Y; Lu L; Jia HL; Qin LX; Dong QZ
    J Hematol Oncol; 2020 Nov; 13(1):152. PubMed ID: 33168028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles and therapeutic value of exosomes in cancer metastasis.
    Wu M; Wang G; Hu W; Yao Y; Yu XF
    Mol Cancer; 2019 Mar; 18(1):53. PubMed ID: 30925925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in Exosome Isolation and Analysis in Health and Disease.
    Ludwig N; Whiteside TL; Reichert TE
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review.
    Donoso-Quezada J; Ayala-Mar S; González-Valdez J
    Crit Rev Biotechnol; 2020 Sep; 40(6):804-820. PubMed ID: 32605394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
    Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
    Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies.
    Allegra A; Petrarca C; Di Gioacchino M; Casciaro M; Musolino C; Gangemi S
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function and therapeutic development of exosomes for cancer therapy.
    Kim SB
    Arch Pharm Res; 2022 May; 45(5):295-308. PubMed ID: 35604532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic and Non-Malignant Pancreatic Exosome Cargo Reveal Distinct Expression of Oncogenic and Prognostic Factors Involved in Tumor Invasion and Metastasis.
    Emmanouilidi A; Paladin D; Greening DW; Falasca M
    Proteomics; 2019 Apr; 19(8):e1800158. PubMed ID: 30893511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiovascular exosome: current perspectives and potential.
    Cosme J; Liu PP; Gramolini AO
    Proteomics; 2013 May; 13(10-11):1654-9. PubMed ID: 23526783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers.
    Lakhal S; Wood MJ
    Bioessays; 2011 Oct; 33(10):737-41. PubMed ID: 21932222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin.
    Hekmatirad S; Moloudizargari M; Moghadamnia AA; Kazemi S; Mohammadnia-Afrouzi M; Baeeri M; Moradkhani F; Asghari MH
    Front Immunol; 2021; 12():692654. PubMed ID: 34149737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.